Virtual Journal Club

Feb. 17, 2020

Join clinical microbiology laboratory directors in discussing recent journal articles in clinical microbiology. Each month a group of presenters will discuss one or two articles in-depth. Journal clubs are held every second Tuesday at 2pm Eastern. 

This activity is free to ASM members.

March 3 Update: Due to COVID-19 the March Session has been moved to April. 


New Antibiotics: Cefiderocol and Lefamulin

April 14 Session

Register Now!

Articles for Discussion

Michael Jacobs et al., ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum B-Lactamases and Carbapenemases, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 1, Jan 2019. DOI: 10.1128/AAC.01801-18.

Susanne Paukner et al., Antibacterial Activity of Lefamulin against   Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program, Antimicrobial Agents and Chemotherapy, Volume 63, Issue 4, Apr 2019. DOI: 10.1128/AAC.02161-18.

Arryn Craney PhD, D(ABMM), Weill Cornell Medicine
Nicholas Moore PhD, MLS(ASCP)cm, Rush University

Matthew Pettengill, PhD, D(ABMM), Thomas Jefferson University

Discussion Panel
Joseph Blondeau, PhD, FCCP, Royal University Hospital, Saskatchewan
Jessica Bohrhunter, PhD, CPEP, CPEP Fellow of the University of Rochester
James Kirby, MD, D(ABMM), Beth Israel Deaconess, Harvard Medical School

Stay tuned for upcoming topics and registration!

Next Session Date

May 12, 2020


Missed a past virtual journal club? Catch up by watching recordings on ASM Events Online


Questions? Email Nicole Jackson at